The One in a Million Podcast
from Novartis Canada Medical Affairs
Barriers and technology in autoinflammatory research – conversation with Dr Dilan Dissanayake
You last listened April 17, 2021
Many researchers face barriers when it comes to their projects, but there are unique barriers when it comes to autoinflammation; today we dig into why. We will also look at the “love/hate” relationship with the COVID-19 pandemic and its effect on autoinflammatory research. Lastly, we’ll continue talking about how collaboration in this space opens up a technical aspect to the research; genomics, proteomics; metabolomics and beyond!
Dr. Dilan Dissanayake is a pediatric rheumatologist in the Autoinflammatory Disease Clinic at the Hospital for Sick Children. In addition to caring for patients with these rare conditions, he applies his Ph.D. training in Immunology to take patient samples into the lab and gain a better understanding of the cellular and molecular processes that contribute to their diseases. He is currently involved in studies to identify rare genetic variants in patients with undiagnosed autoinflammatory conditions, and to use cutting edge approaches to dissect the cellular activation pathways that these variants affect. His work has led to publications in a variety of high-impact journals, and he was the recent recipient of a highly competitive research funding award to continue these explorations.
Our host, Dr. Michelle Batthish (Assistant Professor in the Department of Pediatrics' Division of Rheumatology at McMaster University) invites you to listen into the first episode of the first series of the One in a Million Podcast, which will serve as a background and introduction into the world of autoinflammation. In this episode, she sits down with Dr. Dilan Dissanayake where they explore of world of genetic research.